- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04675307
Multimodal, Task-Aware Movement Assessment and Control: Clinic to the Home
March 2, 2021 updated by: David Levine, Brigham and Women's Hospital
The investigators seek to construct a novel, multimodal, distributed system that facilitates a new paradigm of home-based medical surveillance and treatment for frail older adults centered on timely diagnosis of movement system impairments and personalized intervention.
Measurements from a heterogeneous set of complementary sensors will be combined with clinically-informed and data-learned dynamic models of human motion to enable real-time activity recognition (e.g., sitting, standing, walking) and movement assessments (e.g., speed, repetition, quality).
As the study progresses, the system will be integrated with wearable assistive technology to provide "smart", activity-specific assistance of movement deficits or the activation of caregivers if a decline in function is detected.
Finally, the investigators will test the combined assessment and intervention system in the clinic and the home, identifying challenges and solutions for the scaling up to unconstrained real-world settings.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: David M Levine, MD, MPH, MA
- Phone Number: 617-732-7063
- Email: dmlevine@bwh.harvard.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Recruiting
- Brigham and Women's Hospital
-
Contact:
- David M Levine, MD MPH MA
- Phone Number: 617-732-7063
- Email: dmlevine@partners.org
-
Principal Investigator:
- David M Levine, MD MPH MA
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Study population will consist of frail adults and frail older adults.
Frailty is defined as a state of increased vulnerability and reduced ability to recover after a stressful event, leading to adverse health outcomes.
Description
Inclusion Criteria:
- Age >= 18 years
- Capacity to consent
- Community dwelling
- Ability to follow 3-step commands
- Lives within 15 miles of Boston
Exclusion Criteria:
- Undomiciled
- Active substance use disorder
- Active psychosis
- Domestic violence or neglect
- Inability to communicate with investigators
- Other comorbidities that prevent full participation in the research
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Video and inertial motion unit capture
Time Frame: 1 recording episode, approximately 3 hours
|
Successfully capture video and inertial motion unit capture of subjects as they perform various movement assessments.
|
1 recording episode, approximately 3 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 17, 2021
Primary Completion (Anticipated)
December 1, 2023
Study Completion (Anticipated)
December 2, 2023
Study Registration Dates
First Submitted
December 8, 2020
First Submitted That Met QC Criteria
December 14, 2020
First Posted (Actual)
December 19, 2020
Study Record Updates
Last Update Posted (Actual)
March 4, 2021
Last Update Submitted That Met QC Criteria
March 2, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2020P003474
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Frailty
-
University of PennsylvaniaCompleted
-
Instituto Tecnologico y de Estudios Superiores...Not yet recruiting
-
Longeveron Inc.CompletedAging FrailtyUnited States
-
Longeveron Inc.CompletedAging FrailtyUnited States
-
The Hong Kong Polytechnic UniversityCompleted
-
Xijing HospitalUnknownFrailty SyndromeChina
-
Region ZealandUniversity of Southern DenmarkActive, not recruitingFrailty SyndromeDenmark
-
Neurological Associates of West Los AngelesEnrolling by invitation
-
Ankara Etlik City HospitalNot yet recruiting
-
IRCCS Centro San Giovanni di Dio FatebenefratelliCompleted